글로벌 약물 안전 솔루션 및 약물 안전 감시 시장 – 2031년까지의 산업 동향 및 예측

약물 안전 솔루션 및 약물 안전 감시 시장 분석 및 규모

부작용의 증가와 효과적인 약물 안전 모니터링 시스템에 대한 수요 증가를 포함한 여러 요인이 약물 안전 솔루션과 약물 안전 감시 시장을 주도합니다. 이 시장은 또한 주요 제약 회사의 약물 개발에 대한 투자 증가와 규제 당국이 대중의 안전을 보장하기 위해 약물 안전 감시 서비스를 채택하는 증가로 인해 촉진됩니다. 게다가 인공 지능과 빅 데이터 분석과 같은 새로운 첨단 기술이 시장 성장을 더욱 촉진합니다.

글로벌 약물 안전 솔루션 및 약물 감시 시장 규모는 2023년에 83억 9천만 달러로 평가되었으며, 2031년까지 149억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.5%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Market Definition

Drug safety solutions and pharmacovigilance refer to practices and systems implemented by pharmaceutical companies and regulatory agencies to monitor and ensure the safety of drugs. Pharmacovigilance involves detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems. It aims to improve patient safety and public health by identifying and evaluating the risks associated with pharmaceutical products throughout their lifecycle, from pre-market clinical trials to post-market surveillance.      

Drug Safety Solutions and Pharmacovigilance Market Dynamics

Drivers

• Increasing Prevalence of Adverse Drug Reactions

As the use of pharmaceuticals continues to increase, so does the likelihood of ADRs, necessitating robust pharmacovigilance systems to monitor and manage these risks effectively. With more complex and personalized treatments becoming common, the importance of pharmacovigilance in ensuring patient safety and drug efficacy is increasing. The rising incidence of adverse drug reactions (ADRs) globally is a significant driver for the drug safety solutions and pharmacovigilance market.

• Growing Demand for Personalized Medicine

Personalized medicine requires monitoring patient responses to tailor treatments, highlighting the importance of robust pharmacovigilance systems. As personalized medicine becomes more mainstream, pharmacovigilance will play a crucial role in identifying and managing individualized risks associated with these treatments. This shift towards personalized medicine, driven by advancements in genomics and biomarker research, drives the need for more comprehensive pharmacovigilance strategies and market growth.

Opportunities

• Expansion of Pharmacovigilance Outsourcing

The expansion of pharmacovigilance outsourcing refers to the increasing trend among pharmaceutical companies to delegate pharmacovigilance activities to external service providers. As pharmaceutical companies face growing regulatory requirements and the need for specialized expertise in pharmacovigilance, they opt to outsource these functions to third-party service providers. This allows companies to access specialized knowledge and resources while reducing operational costs. Outsourcing pharmacovigilance tasks is expected to grow rapidly, offering new opportunities for market growth.

• Integration of Real-World Data

Integrating real-world data (including electronic health records, claims data, and patient registries, can provide valuable insights into drug safety and effectiveness in real-world settings. By leveraging RWD, pharmacovigilance professionals can enhance signal detection, improve risk assessment, and optimize post-marketing surveillance, leading to more efficient and effective pharmacovigilance practices and creating new opportunities for the market.

Restraints/Challenges

• Regulatory Compliance and Reporting Burden

Regulatory requirements for pharmacovigilance are becoming more complex and stringent, requiring companies to invest significant resources in compliance efforts. This includes the timely and accurate reporting of adverse drug reactions (ADRs), maintaining comprehensive pharmacovigilance systems, and ensuring compliance with evolving regulations across different regions. Failure to comply with these requirements can lead to regulatory sanctions, fines, and reputational damage, posing a significant challenge to the market.

• Data Quality and Integration

Pharmacovigilance relies heavily on collecting, analyzing, and interpreting vast amounts of data from diverse sources, including clinical trials, post-market surveillance, and real-world evidence. Ensuring this data's quality, consistency, and reliability is critical for effective pharmacovigilance practices. However, data quality issues, such as incomplete or inaccurate reporting, data silos, and lack of standardization, can hinder the ability of companies to derive meaningful insights from their data and effectively identify and manage drug safety risks. The quality and integration of data is a major challenge for the market.

This drug safety solutions and pharmacovigilance market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug safety solutions and pharmacovigilance market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Drug Safety Solutions and Pharmacovigilance Market Scope

The drug safety solutions and pharmacovigilance market is segmented on the basis of type, product, functionality, end user, delivery, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Software
• Services

 Product

• Standard Form
• Customized Form

Functionality

• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software

 Delivery

• On-Premise Delivery Mode
• On-Demand/Cloud-Based (SAAS) Delivery Mode

 End Users

• Biotechnology and Pharmaceuticals
• Contract Research Organizations (CROS)
• Hospitals
• KPOs/BPOs
• Healthcare Providers

 Distribution Channel

• Direct Sales
• Retail Sales

Drug Safety Solutions and Pharmacovigilance Market Regional Analysis/Insights

The drug safety solutions and pharmacovigilance market is analyzed and market size insights and trends are provided by country, type, product, functionality, end user, delivery, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to the escalating rates of drug abuse and adverse drug reactions.  Major regional pharmaceutical companies are investing significantly in new drug research, further propelling market growth. These factors, coupled with the stringent regulatory framework in North America, are driving the demand for pharmacovigilance services in the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to the expanding government initiatives and investments to improve healthcare infrastructure and services. Furthermore, there is a growing awareness among patients in the region regarding the importance of pharmacovigilance in ensuring drug safety.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

약물 안전 솔루션 및 약물 감시 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 약물 안전 솔루션 및 약물 감시 시장을 위한 다양한 종류의 제품 설치 기반, 생명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 약물 안전 솔루션 및 약물 감시 시장에 미치는 영향. 이 데이터는 2011-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 약물 안전 솔루션 및 약물 안전 감시 시장 점유율 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

약물 안전 솔루션 및 약물 감시 시장에서 활동하는 주요 업체는 다음과 같습니다.

• PPD 주식회사(미국)
• Drug Safety Solutions Limited(미국)
• C3i(미국)
• 전 세계 임상 시험(미국)
• 바이오클리니카(미국)
• 유나이티드 바이오소스 LLC(미국)
• 에노브(홍콩)
• AB Cube SAS(프랑스)
• Labcorp 약물 개발(미국)
• Accenture(아일랜드)
• ICON plc (미국)
• Ergomed plc (영국)
• IQVIA(미국)
• 젠팩트(미국)
• 인지(미국)
• 파렉셀 인터내셔널 코퍼레이션(미국)
• 아리스글로벌(미국)

SKU-50238